Glucose-6-Phosphate Dehydrogenase Deficiency and Coronavirus Disease 2019

© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..

In this cohort study conducted in a national healthcare organization in Israel, we found that individuals with glucose-6-phosphate dehydrogenase deficiency had an increased risk of coronavirus disease 2019 (COVID-19) infection and severity, with higher rates of hospitalization and diagnosed long COVID.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:77

Enthalten in:

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 77(2023), 7 vom: 05. Okt., Seite 972-975

Sprache:

Englisch

Beteiligte Personen:

Israel, Ariel [VerfasserIn]
Berkovitch, Matitiahu [VerfasserIn]
Merzon, Eugene [VerfasserIn]
Golan-Cohen, Avivit [VerfasserIn]
Green, Ilan [VerfasserIn]
Ruppin, Eytan [VerfasserIn]
Vinker, Shlomo [VerfasserIn]
Magen, Eli [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
EC 1.1.1.49
G6PD deficiency
Glucose-6-phosphate dehydrogenase
Glucosephosphate Dehydrogenase
Journal Article
Research Support, N.I.H., Intramural

Anmerkungen:

Date Completed 30.10.2023

Date Revised 06.11.2023

published: Print

Citation Status MEDLINE

doi:

10.1093/cid/ciad348

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM357842189